Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China
· Delayed Price · Currency is CNY 49.90
-0.85 (-1.67%)
At close: Mar 9, 2026
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 23.19 billion as of March 9, 2026. Its market cap has increased by 32.97% in one year.
Market Cap
23.19B
Enterprise Value
22.32B
Revenue
801.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.90
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 23.19B, an increase of 41.03%. That is a compound annual growth rate of 8.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 23.58B | -11.23% |
| Dec 31, 2025 | 26.56B | 54.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Nhwa Pharmaceutical Co., LTD | 23.04B |
| Zhejiang Huahai Pharmaceutical | 23.56B |
| Wedge Industrial | 21.88B |
| Jilin Aodong Pharmaceutical Group | 21.52B |
| Tasly Pharmaceutical Group | 21.02B |
| Chengdu Kanghong Pharmaceutical Group | 25.61B |
| Hubei Jumpcan Pharmaceutical | 25.64B |
| Kangmei Pharmaceutical | 25.86B |